| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥58837.8B | ¥64039.0B | -8.1% |
| Operating Income | ¥1577.8B | ¥3483.1B | -54.7% |
| Profit Before Tax | ¥1772.2B | ¥3956.6B | -55.2% |
| Net Income | ¥1389.2B | ¥3087.7B | -55.0% |
| ROE | 2.7% | 6.3% | - |
FY2026 Q3 consolidated results show revenue of 58,837.8B yen (YoY -8.1%), operating income of 1,577.8B yen (YoY -54.7%), ordinary income not separately disclosed, and net income of 1,389.2B yen (YoY -55.0%). The sharp profit decline reflects deteriorating operating margins despite maintaining gross profit levels, as selling, general and administrative expenses increased relative to declining sales. Operating cash flow of 412.4B yen exceeded net income, confirming cash-backed earnings, though free cash flow turned negative at -146.2B yen due to capital expenditures of 487.8B yen. Total assets increased to 101,471.3B yen with equity of 52,268.1B yen, maintaining an equity ratio of 49.5%. Full-year guidance projects revenue of 7,700.0B yen, operating income of 290.0B yen, and net income of 240.0B yen, indicating continued challenges in operational efficiency recovery.
[Profitability] ROE of 2.4% represents significant deterioration from prior year levels, driven primarily by net profit margin compression to 2.1% as operating margin fell to 2.7%. The margin decline stems from revenue contraction of 8.1% coupled with relatively fixed cost structure in SG&A expenses. Operating income margin of 2.7% compares to company's 3-year trend showing decline from 5.1% in 2024. Gross profit margin maintained at 31.8% indicates pricing power or product mix stability at the manufacturing level, with profitability pressure concentrated in operating expenses. [Cash Quality] Cash and cash equivalents stand at 751.2B yen within total current assets of 4,001.3B yen. Operating cash flow of 412.4B yen represents 3.29 times net income, demonstrating strong cash conversion from accrual earnings. Cash conversion ratio of 3.29 significantly exceeds industry median of 1.24, indicating superior earnings quality. [Investment Efficiency] Total asset turnover of 0.580 times reflects asset base expansion outpacing revenue growth, with total assets increasing 8.6% to 101,471.3B yen. ROIC calculation indicates returns below target levels given the current profit margins. Property, plant and equipment increased 4,878.3B yen, representing aggressive capital deployment requiring future productivity validation. Inventory turnover period of 101 days signals working capital inefficiency and potential obsolescence risk. [Financial Health] Equity ratio of 49.5% matches industry median of 49.5%, positioning the company at the middle of sector distribution. Debt-to-capital ratio of 17.8% with interest-bearing debt of 1,134.1B yen indicates conservative leverage utilization. Financial leverage of 1.94 times remains below industry median of 1.53 times when adjusted for asset base. Net debt to EBITDA positioned favorably given cash holdings, though operating profit decline requires monitoring of coverage metrics.
Operating cash flow of 412.4B yen exceeding net income by 3.29 times confirms the quality of reported earnings, with working capital movements contributing positively despite inventory build of 89.9B yen. The inventory increase of 70.4B yen consumed cash while accounts payable increased 31.6B yen, partially offsetting working capital pressure. Investing cash flow of -558.5B yen was dominated by capital expenditures of 487.8B yen, representing 17.9% growth in property, plant and equipment to support future revenue generation. This aggressive CapEx deployment in a declining revenue environment positions capital allocation as a key watch point for return validation. Free cash flow of -146.2B yen indicates the company consumed more cash in investments than generated from operations, with CapEx/Depreciation ratio suggesting capacity expansion beyond maintenance requirements. Financing activities reflect ongoing dividend commitments that combined with negative FCF create sustainability questions under current profit levels. Cash position increased modestly despite negative FCF, benefiting from balance sheet liquidity management. The disconnect between strong operating cash generation and negative free cash flow centers on investment intensity, requiring scrutiny of project returns to justify continued capital deployment at current levels.
Operating income of 157.8B yen compared to net income of 138.9B yen indicates relatively limited non-operating impact, with equity method investment gains of 15.9B yen providing partial support. Financial income and expenses netted to a small positive contribution, suggesting limited reliance on non-core activities for reported profits. The operating-to-net income conversion demonstrates that core business performance drives overall results, with effective tax rate of 21.6% applied to pre-tax income of 177.2B yen. Non-operating income represents approximately 0.3% of revenue, composed primarily of equity method gains and minimal financial activities, confirming earnings are substantially derived from operations. Operating cash flow of 412.4B yen substantially exceeding net income by 3.29 times provides strong evidence of earnings quality, indicating reported profits convert to cash without significant accrual distortions. The divergence between comprehensive income of 476.9B yen and net income of 138.9B yen reflects 338.0B yen in other comprehensive income, primarily from foreign exchange translation adjustments and financial asset revaluations that do not impact cash flows. Accruals assessment shows healthy cash realization with inventory increase being the primary working capital drag, while receivables and payables management contributed neutrally. Overall earnings quality remains sound from a cash conversion perspective, though the sustainability of current profit levels faces pressure from operational efficiency challenges rather than accounting quality concerns.
Operational efficiency deterioration poses the primary risk, with operating margin contracting from historical 5.1% to current 2.7% as revenue declined 8.1% while cost structure remained relatively inflexible. The company faces 54.7% operating income decline that exceeds revenue contraction by significant margin, indicating operating leverage working unfavorably and requiring substantial cost restructuring or revenue recovery to restore profitability. Inventory management risk intensifies with days inventory outstanding reaching 101 days and absolute inventory increasing 89.9B yen during a period of declining sales, creating exposure to obsolescence, markdown, or write-down scenarios if demand recovery fails to materialize. The inventory build in a contracting revenue environment suggests either supply chain timing mismatches or demand forecasting challenges requiring near-term resolution. Capital allocation sustainability emerges as third critical risk, with dividend payout ratio calculated at 94.0% of net income and negative free cash flow of -146.2B yen creating tension between shareholder returns, growth investments, and financial flexibility. The company maintains capital expenditure of 487.8B yen while generating insufficient free cash flow to cover dividends, implying reliance on balance sheet cash or external financing to sustain current capital allocation policies. Full-year guidance projecting further operating income decline of 32% creates uncertainty around both profitability recovery timing and dividend policy sustainability under compressed earnings.
[Industry Position] (Reference - Proprietary Analysis) The company operates within the manufacturing sector showing mixed positioning relative to industry medians. Profitability metrics reveal challenges with ROE of 2.4% substantially below industry median of 5.0% and operating margin of 2.7% significantly trailing the sector median of 8.3%, positioning the company in the lower quartile for profitability performance. Net profit margin of 2.1% compares unfavorably to industry median of 6.3%, indicating structural margin pressure beyond peer group norms. Financial health indicators show equity ratio of 49.5% precisely at industry median, demonstrating comparable capital structure stability to sector peers. The conservative debt positioning with net debt/EBITDA favorable to industry median of -1.11 provides financial flexibility advantage relative to peers. Efficiency metrics present contrasting signals, with asset turnover of 0.580 times matching industry median of 0.58 exactly, suggesting comparable asset utilization intensity. However, inventory turnover of 101 days compares closely to industry median of 108.81 days, indicating working capital efficiency aligns with sector norms despite recent deterioration. Cash conversion ratio of 3.29 significantly exceeds industry median of 1.24, representing a relative strength in converting profits to cash compared to manufacturing peers. Revenue growth of -8.1% underperforms industry median of 2.7%, placing the company among weaker performers in top-line expansion. The CapEx/D&A ratio indicates investment intensity above maintenance levels, though specific comparison requires context on industry median of 1.44. Overall industry positioning shows strong balance sheet fundamentals and cash generation quality offset by below-median profitability and revenue momentum, suggesting operational improvement opportunity exists within a financially stable foundation. (Industry: Manufacturing sector, Comparison periods: FY2024-2026 Q3, Source: Proprietary analysis)
Profitability restoration pathway represents the central narrative, with operating margin compression from 5.1% to 2.7% indicating substantial recovery potential if cost structure realignment progresses. The company's ability to maintain 31.8% gross margin while operating margin deteriorated suggests the efficiency gap resides in SG&A expenses rather than manufacturing competitiveness, pointing toward management execution on cost controls as the primary near-term value driver. The divergence between 3.29x cash conversion ratio and compressed profit margins creates an unusual profile where earnings quality remains high despite weak profitability levels, implying operational improvements would translate efficiently to both reported profits and cash generation. Capital allocation strategy requires validation, with 487.8B yen in capital expenditures during revenue contraction creating a thesis dependent on future project returns. The 17.9% growth in PP&E assets during a period of declining sales positions 2026-2027 as a critical period for demonstrating return on invested capital improvement, as the investment phase must transition to productivity gains to justify the deployment. Free cash flow turning negative at -146.2B yen while maintaining 94.0% dividend payout ratio creates sustainability questions that likely resolve through either profit recovery, dividend adjustment, or moderated investment intensity in coming periods. The comprehensive income of 476.9B yen substantially exceeding net income by 338.0B yen primarily from foreign exchange effects indicates balance sheet carries unrealized gains that could support book value but also introduces volatility from currency movements. Full-year guidance projecting continued headwinds with revenue down 9% and operating income down 32% establishes conservative expectations that create potential for positive surprises if operational efficiency initiatives gain traction earlier than forecast.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.